Skip to content
  • About
    • Who We Are
    • Team
    • Careers
  • Science
  • Pipeline
  • Investors
  • News
  • Contact Us

News > Press releases

Categories

  • Press releases (11)

Related News

  • ImmunoGenesis to Present Pre-Clinical Data from Lead Program at Society for Immunotherapy of Cancer Conference
  • ImmunoGenesis CEO James Barlow to Present on Company’s Immuno-Oncology Clinical Development Targeting Immune-Excluded, “Cold” Cancers at BIO CEO & Investor Conference
  • ImmunoGenesis CEO James Barlow to Present on Company’s Immuno-Oncology Clinical Development Targeting Immune-Excluded, “Cold” Cancers at Biotech Showcase
Back to all news

Press releases

ImmunoGenesis Awarded $15.5 M Grant from Cancer Prevention and Research Institute of Texas (CPRIT)
August 24, 2020

Announcing a $15.5 million grant from Cancer Prevention and Research Institute of Texas (CPRIT) to advance our development of IMGS-001, the dual-specific checkpoint inhibitor and tumor microenvironment remodeling agent.

Read more

Posts navigation

Newer posts

Excited about what you see?

Learn more
Who We Are Team Careers Science Pipeline Investors News Contact Us

Privacy Policy Terms and Conditions
Who We Are Team Careers Science Pipeline Investors News Contact Us

© 2023 ImmunoGenesis®    All Rights Reserved.    02-2023-v.4

Privacy Policy Terms and Conditions